Multifocal Motor Neuropathy
📧 Sign up to get email alerts when something new happens for Multifocal Motor Neuropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Do IgG Level Variations in CIDP and MMN Patients Following Initial Intravenous IVIg Treatment Correlate With Ultimate Dosing
A completed clinical trial investigating whether IgG level fluctuations after initial intravenous immunoglobulin treatment relate to subsequ…
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: A Study of TAK-771 in Japanese Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN) [Phase 3]
Phase 3 study of TAK-771 in Japanese participants with CIDP and MMN has posted results and is listed as not currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: A Study of TAK-771 in Japanese Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN) [Phase 3]
Phase 3 trial of TAK-771 in Japanese participants with CIDP and MMN completed; results posted.
-
CLINICAL_TRIALS trial_result · 2024-10-18Clinical Trial Update: A Clinical Trial to Investigate the Safety and Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics and Immunogenicity of 2 Dose Regimens of ARGX-117 in Adults with Multifocal Motor Neuropathy [Phase 2]
A Phase 2 trial evaluating two dose regimens of ARGX-117 in adults with Multifocal Motor Neuropathy has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: Efficacy and Safety of HyQvia (Immunoglobulin 10% With Recombinant Hyaluronidase) in Multifocal Motor Neuropathy (MMN) [Phase 2]
Phase 2 trial results assess the efficacy and safety of HyQvia (immunoglobulin 10% with recombinant hyaluronidase) in patients with Multifoc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-08-31Clinical Trial Update: HyQvia in Multifocal Motor Neuropathy [NA]
Clinical trial update on HyQvia for Multifocal Motor Neuropathy; no phase or results information provided.
-
CLINICAL_TRIALS trial_result · 2016-07-19Clinical Trial Update: LIME Study (LFB IVIg MMN Efficacy Study) [Phase 3]
Phase 3 study assessing intravenous immunoglobulin (IVIg) for multifocal motor neuropathy has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Multifocal Motor Neuropathy. [Phase 3]
Phase III trial of NPB-01 maintenance therapy for multifocal motor neuropathy has completed.
-
CLINICAL_TRIALS trial_result · 2015-09-22Clinical Trial Update: Immunoglobulin Dosage and Administration Form in CIDP and MMN
A completed clinical trial update from Rigshospitalet evaluating immunoglobulin dosage and administration form for CIDP and MMN.
-
CLINICAL_TRIALS trial_result · 2014-12-12Clinical Trial Update: Change of Nerve Conduction Properties in IVIg Dependent Neuropathies
This update describes a clinical trial examining changes in nerve conduction properties in IVIg-dependent neuropathies, including Guillain-B…
-
CLINICAL_TRIALS trial_result · 2013-08-01Clinical Trial Update: A Study of Purified Human Antibodies Administered Subcutaneously to Patients With Multifocal Motor Neuropathy (MMN) [Phase 2]
Phase 2 study evaluating subcutaneous administration of purified human antibodies in patients with multifocal motor neuropathy has completed…
-
CLINICAL_TRIALS trial_result · 2013-03-13Clinical Trial Update: Study of the Effectiveness of Intravenous Immune Globulin (10%) for the Treatment of Multifocal Motor Neuropathy [Phase 3]
Phase 3 trial evaluating intravenous immunoglobulin (10%) for multifocal motor neuropathy has completed with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2008-02-21Clinical Trial Update: Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy [Phase 2]
The Phase 2 trial evaluating subcutaneous immunoglobulin for Multifocal Motor Neuropathy has completed.